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Abstract
Nanoparticles have the potential to increase the efficacy of anticancer drugs whilst reducing
off-target side effects. However, there remain uncertainties regarding the cellular uptake
kinetics of nanoparticles which could have implications for nanoparticle design and delivery.
Polymersomes are nanoparticle candidates for cancer therapy which encapsulate chemo-
therapy drugs. Here we develop a mathematical model to simulate the uptake of polymer-
somes via endocytosis, a process by which polymersomes bind to the cell surface before
becoming internalised by the cell where they then break down, releasing their contents
which could include chemotherapy drugs. We focus on two in vitro configurations relevant to
the testing and development of cancer therapies: a well-mixed culture model and a tumour
spheroid setup. Our mathematical model of the well-mixed culture model comprises a set of
coupled ordinary differential equations for the unbound and bound polymersomes and asso-
ciated binding dynamics. Using a singular perturbation analysis we identify an optimal num-
ber of ligands on the polymersome surface which maximises internalised polymersomes
and thus intracellular chemotherapy drug concentration. In our mathematical model of the
spheroid, a multiphase system of partial differential equations is developed to describe the
spatial and temporal distribution of bound and unbound polymersomes via advection and
diffusion, alongside oxygen, tumour growth, cell proliferation and viability. Consistent with
experimental observations, the model predicts the evolution of oxygen gradients leading
to a necrotic core. We investigate the impact of two different internalisation functions on
spheroid growth, a constant and a bond dependent function. It was found that the constant
function yields faster uptake and therefore chemotherapy delivery. We also show how
various parameters, such as spheroid permeability, lead to travelling wave or steady-state
solutions.
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1 Introduction
Over one quarter of cancer patients undergo chemotherapy [1]. Unfortunately, the systemic
nature of drug delivery and lack of biological specificity of chemotherapeutic agents can result
in severe side effects, thus reducing the dose that can be administered [2]. However, in recent
years nanoparticle-mediated drug delivery has been developed to target cancer cells, and has
shown potential in reducing side effects, whilst increasing intratumoural drug concentration
in comparison to traditional chemotherapy [3].
Numerous nanoparticle formations have been investigated for use with anticancer
drugs [3]; here we focus on polymersomes which have been shown to have therapeutic
potential for head and neck squamous cell carcinoma (HNSCC) patients, among others [4].
HNSCC has extremely poor prognosis outcomes, partly because the chemotherapy dose
required to treat the cancer results in significant toxicity to the patient. Therefore new treat-
ment strategies are desperately needed which target the cancer cells and minimise damage
to the rest of the body. We previously found that polymersomes bind to and are preferen-
tially taken up by HNSCC cells via class B scavenger receptors that are exposed on their cell
surface [5].
Polymersomes are pH-sensitive synthetic diblock copolymers that self assemble into nano-
metre-sized vesicles at a neutral pH and disassemble at an acidic pH (below 6.4) [6]. During
assembly the polymersomes can encapsulate compounds, such as anticancer drugs, within
their core [5, 7]. They are taken up by cells via receptor-mediated endocytosis [8], a process
by which the nanoparticles bind to receptors on the cell surface. Once sufficient bonds have
formed between the polymersome and cell surface receptor, the polymersome is internalised,
becoming surrounded by the plasma membrane that forms an endosome. Endosomal pH is
highly acidic which causes the nanoparticle to rapidly disassemble. In turn this causes the
endosome to rupture, releasing the anti-cancer drug into the cell cytosol [6]. This process is
visualised in Fig 1.
At present, there are still many unknowns around the factors that determine the kinetics of
nanoparticle binding, uptake and subsequent chemotherapy release. A more complete under-
standing of these kinetics will help to enable the optimisation of nanoparticle design and treat-
ment strategies. Here we use mathematical and computational modelling as a complementary
tool to existing experimental studies (for example see Murdoch et al [9]) to explore the mecha-
nisms which underpin the process of binding, internalisation and drug release in order to elu-
cidate optimal polymersome design. Computational modelling of chemotherapy delivery to,
and distribution within, tumours is a large field of research [10–14].
Previously we developed a mathematical model to describe polymersome uptake via recep-
tor-mediated endocytosis (RME) in a well-mixed culture model [15]. We parameterised the
model using in vitro experiments and subsequently performed an investigation into the
parameters that affect nanoparticle uptake by HNSCC cells. In this study we apply the model
to two systems that mimic in vitro experimental setups often used in the preclinical stages of
drug development. Firstly, we model polymersome uptake in a spatially invariant system that
mimics cells cultured in 2D monolayers and focus on key uptake parameters and behaviours
when there is abundant polymersome supply. We nondimensionalise the model and perform
a singular perturbation analysis to find analytical solutions for the fast binding kinetics of the
system. This provides insights into key system behaviours, including the number of binding
events that take place before internalisation, which is important because this affects uptake
rates, as well as the optimal number of ligands on the particle surface. In an extension to our
previous model we also include cells, including their proliferation and death, which impacts
uptake, and therefore concentrations of free nanoparticles.
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It is important to extrapolate in vitro parameters to more physically realistic systems. There-
fore we also apply our model to 3D tumour spheroids as they are a more realistic representa-
tion of in vivo tumour tissue [16] than typical 2D monolayer cultures, yet are a controllable in
vitro model in which to include the effects of spatial variations in treatment. Due to diffusion
limitations of oxygen, tumour spheroids form a necrotic core with a viable outer rim of prolif-
erating cells. This behaviour reflects in vivo conditions where heterogeneous vasculature in
solid tumours results in hypoxic and ultimately necrotic intra-tumour regions forming. Fur-
thermore, when delivering polymersomes to the spheroid surface we can gain insights into
how cells will be impacted at varying distances from a polymersome source, such as a blood
vessel. Using spheroids to investigate drug delivery is a common experimental approach for
investigating chemotherapy drug delivery [5], as well as a common area of research in compu-
tational modelling [17–19].
We use a multiphase model to investigate the effects of various parameters on spheroid
growth and we investigate the long term growth of spheroids by exploring travelling wave and
steady state behaviours for the tumour boundary. Despite the wealth of literature, as far as we
are aware, there are no models published that account for polymersome uptake in a spheroid
model which accounts for cell surface receptor recycling and internalisation rates that are poly-
mersome-cell bond dependent, as well as time dependent, which our model is. The goal of our
investigation is to identify controllable parameters that could be fed into experimental design
of polymersomes in the future.
In the next section, we present the mathematical formulation of our well-mixed system, fol-
lowed by parameterisation and nondimensionalisation of the model and then a perturbation
Fig 1. A schematic of the ligand-receptor binding process and internalisation via receptor-mediated endocytosis of polymersomes. (A) The structure
of polymersomes. (B) Receptor-ligand binding, cell surface receptors bind with ligands on the polymersome surface. (C) Cell membrane deformation (D)
The polymersome becomes enclosed by the cell membrane, which breaks away to form an endosome. (E) The polymersome ruptures due to the acidic
environment of the endosome and releases its contents. Changes in the osmotic pressure with the endosome causes it to rupture, releasing the
polymersomes encapsulated chemotherapy drug into the cell. The cell surface receptors that were encapsulated with the polymersome are recycled to the
cell surface.
https://doi.org/10.1371/journal.pone.0254208.g001
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analysis of the early time periods in the model. Next we present the spheroid model formula-
tion, again followed by parameterisation and nondimensionalisation. We develop numerical
solutions for both the well-mixed and spheroid systems, and use them to determine the maxi-
mum number of bound and internalised polymersomes as well as the impact of various inter-
nalisation functions, all of which play a key role in determining the amount of chemotherapy
drug delivered to the tumour cells.
2 Well-mixed model
Our first step in cancer drug treatment development with real tissue was to adminster the drug
to 2D cell monolayers. This is in order to determine dosing, mechanisms of action, effective-
ness compared with established drugs and interactions with other drugs. Here, the polymer-
somes are assumed to be well-distributed throughout the system, and so we treat this as a
spatially invariant system. A simple schematic of this experimental set up is shown in Fig 2.
This is a very common and simple experimental set up, used not just in cancer research but
in many applications for other diseases. Mathematical modelling can be used to aid experi-
ments since a large parameter space can be explored quickly. For example, here the number of
ligands on the polymersome surface can be quickly varied in order to determine the optimal
number for effective treatment. Once key parameters have been identified through modelling
these can then be used in experimental systems, thus reducing the time required for these
experiments.
2.1 Mathematical formulation
The mathematical framework for polymersome uptake in a well-mixed culture model pre-
sented here closely follows that of our previously published model. Here we extend the model
[15] to include time-varying cell concentration, which we previously assumed to be constant.
We use a system of n+ 5 ordinary differential equations to describe the uptake of polymer-
somes (see Fig 1), where n is the maximum number of bonds that can form between the
Fig 2. A schematic of the experimental setup of cancer cells and polymersomes in a 2D monolayer cell culture. Cells and seeded in the dish and grown
until they have reached optimal capacity. Then therapy is added in order to determine the treatment dosing, mechanisms of action, effectiveness compared
to established drugs and interactions with other drugs in a biological environment. The schematic shows the addition of polymersomes to the 2D
monolayers. D = diameter.
https://doi.org/10.1371/journal.pone.0254208.g002
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polymersome and receptors on the cell surface. We use the same assumptions in our model set
up as we did previously. We assume that the system is well-mixed, i.e cells and particles are
evenly distributed in space which is representative of in vitro conditions, and so ignore any
spatial effects. Furthermore we assume that there are a fixed number of available ligands on
the polymersome surface that can bind to free cell surface receptors.
Step 1 of RME is the binding of receptors to ligands (see Fig 1a), and therefore the number
of free ligands on a polymersome changes over time due to binding with cell surface receptors.












where L is the moles of free vesicle ligands per cm3, ka is the rate of receptor-ligand binding
per minute and kd is the dissociation rate per minute, F is the moles of cell receptors per cm3
and B1 is the moles of receptor-ligand complexes bound with one bond per cm3. Here the first
term on the RHS of Eq (1) accounts for binding of a free polymersome to a single cell receptor
and the second term accounts for dissociation of that bond such that particles are no longer
bound to the cell.
From Eq (1) we can calculate the number of free polymersomes per cm3, V, by
VðtÞ ¼ L=l; ð2Þ
where l is the fixed moles of free ligands per polymersome. We use the law of mass action to























complex with 1 bond
ð3Þ
where NA is Avogadro’s constant, B2 is the moles of receptor-ligand complexes bound with
two bonds per cm3, kin is the polymersome internalisation rate per minute and ρl and ρf are the
fraction of ligands and receptors respectively that are available for 2-D binding, i.e only ligands
and receptors within a certain range can form bonds. The term 2-D binding is used to describe
the subsequent binding after one initial receptor-ligand bond had formed.
Eq (3) involves terms that are functions of ρl and ρf. In the third term on the RHS of Eq (3),
(ρl lNA − 1) represents the ligands available on the polymersome for subsequent binding after
the initial binding event. The term describes that there is one less ligand available for subse-
quent binding, in which the polymersome would become bound to the cell with two bonds
(for example see Fig 1B). The fourth term on the RHS represents dissociation of a bond, mean-
ing that a new receptor and ligand are now free binding at a rate 2kd (where the factor 2 repre-
sents that any one of the two bonds can dissociate). Internalisation of polymersomes occurs at
a constant rate kin; in this well-mixed model we assume that the binding rate and internalisa-
tion rate are independent of the number of bonds that have already formed following our pre-
viously published model [15]. Bond dependent internalisation is explored later in this paper.
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where 2� i� n − 1 and n is the maximum number of ligand-receptor bonds that can form.
The number of receptor-ligand complexes bound by n bonds change over time by,
dBn
dt
¼ kaðrllNa   ðn   1ÞÞrf FBn  1
zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{
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complex with n bonds
ð5Þ
When a maximal number of bonds, n, is reached, polymersomes are internalised into endo-
somes (see Fig 1D.ii). The acidic environment of the endosome causes polymersomes to break
down and release the encapsulated drug. The rate of change of internalised polymersomes















Internalised polymersomes are lost due to polymersome rupture at an assumed constant rate,
the rupture rate db. When polymersomes rupture within the cell they release the encapsulated










where P is the concentration of intracellular drug per cm3. The release of the drug is propor-
tional to the rupture of the polymersome, ν, and we also include a decay in drug activity which
we assume occurs at constant rate, dp, which corresponds to uptake or removal of the chemo-
therapy drug.
During the process of binding there is a change in the number of free receptors, F, on the
cell surface. This is because once a receptor binds with a ligand it is no longer free to bind to
other ligands, and becomes internalised in the process of endocytosis. Once inside the cell, the
receptors are recycled back to the cell surface [20] (see Fig 1E). We describe this rate of change
PLOS ONE A mathematical investigation into the uptake kinetics of nanoparticles in vitro
PLOS ONE | https://doi.org/10.1371/journal.pone.0254208 July 22, 2021 6 / 35










ðrllNa   iÞrf FBi
zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{














where we have assumed that receptors have a limited life on the cell surface, with the constant
linear decay rate df. We assume that receptor production occurs on the cell surface and that
receptors are recruited to the cell surface at a rate proportional to the number of bound recep-
tors. We base these assumptions on the similar model of Ghaghada et al [21] who investigate
receptor recycling and nanoparticle-cell bonds through receptor-mediated targeting for lipo-
somes. We describe receptor recycling using a function of the total number of bound recep-
tors, R(btot), where btot is the total number of bound complexes per cell. We assume R(btot) is
constant if there are no bound receptors (btot = 0), otherwise we assume an increasing saturat-
ing function dependent on the total number of bound complexes per cell. R(btot) is given by











m is the number of tumour cells per cm3, α is the Hill exponent, c1 is the rate of receptor pro-
duction and c2 and c3 characterise the hill equation. Here c2 is the maximum recycling rate and
c3 is the value at which the half maximum of the function R(btot) is reached.
In an extension to our previous model we describe how the tumour cell density changes
over time due to the balance of proliferation and death through
dm
dt










where m is the number of cells per cm3, the carrying capacity of the system is K and we assume
that the cells undergo logistic proliferation at constant rate, r. We include cells in our model
since the number of cells directly correlates to the uptake amount of nanoparticles and there-
fore the number of remaining free polymersomes. Cell death is described by the function g(ϕ),
which we assume is constant when there is no intracellular drug present due to natural cell
death, otherwise it is an increasing saturating function of the intracellular drug concentration
[22]. Cell death is then described through






where �ðtÞ ¼ Pm describes the mole of drug per cell, P is the moles of drug per cm
3, P0 is the
drug concentration that produces a 50% maximal response, dm is the natural cell death, β is the
Hill exponenent and μ is the cell death rate due to drug delivery. The functions of cell death,
g(ϕ), and receptor recycling, R(btot) are generalised hill equations which are commonly used to
model cell kinetics and nutrient consumption, for example see references [22–24].
We further impose the following initial conditions,
mð0Þ ¼ M0; Vð0Þ ¼ V0; Fð0Þ ¼ F0;
Bið0Þ ¼ 0; Binð0Þ ¼ 0 and Pð0Þ ¼ 0;
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where i = 1, . . ., n, M0 is the initial cell concentration, V0 is the initial polymersome concentra-
tion, F0 is the initial cell surface receptor concentration, Bi(0) is the concentration of polymer-
somes bound with i complexes, Bin(0) is the internalised polymersome concentration and P(0)
is the released drug concentration, all at time t = 0. These conditions state that initially there
are no bound or internalised polymersomes present when the cells and particles are mixed
together and therefore there is no released drug.
2.2 Parameterisation
The parameterisation of the system proved difficult since the majority of the parameters for
specific polymersome binding are unknown due to a lack of relevant experimental data. Hence
we look to a similar system of liposomal targeting which has similar dynamics to those of poly-
mersome targeting and is more well understood experimentally. Specifically we look to use
parameters from a liposomal modelling study by Ghaghada et al. [21], in which targeted lipo-
somes bind to folate receptors of C6 glioma cells. The parameter values used in the subsequent
analysis are shown in Table 1. Further information on how the parameters were chosen is pro-
vided in the S1 File.
2.3 Nondimensionalisation
We non-dimensionalise the model in order to understand the dominant terms in the system
and to enable prioritisation of the parameters needed for future experiments. We rescale the
Table 1. Model parameter values. Where no data were available in the literature we estimated parameters values to match experimental observations. See S1 File.
Parameter Dimensional Value Dimensionless Values Reference
Initial cell concentration, M0 5 × 107 cell cm−3 1 [25]
Initial polymersome concentration, V0 1010 polymersome cm−3 1 estimate
Initial cell surface receptor concentration, F0 1.66 × 10−20 mol cell−1 1 [21]
Half maximal drug concentration, P0 4.15 × 10−14 mol cell−1 - estimate
Cell proliferation rate, r 6 × 10−5 min−1 - [25]
Tissue carrying capacity, K 5 × 107 cells cm−3 - estimate
polymersome binding rate, ka 3.7010 × 108 mol−1min−1cm3 0.4451 [21]
polymersome dissociation rate, kd 3.7010 × 10−5 min−1 0.0533 [21]
polymersome internalisation rate, kin 0.6124 min−1 887.5 [21]
Avogadros constant, Na 6.022 × 1023 molecules - -
Ligands per polymersome, l � Na 1200 ligands polymersome−1 - estimate
Receptor decay rate, df 0.03 min−1 43.203 [26]
Fraction of receptors available for binding, ρf (0, 1] - estimate
Fraction of ligands available for binding, ρl (0, 1] - estimate
polymersome rupture rate, db 2.3 min−1 3.3122 [8]
Drug decay rate, dp 1.2 min−1 1739 estimate
Natural cell death rate, dm 0.01min−1 724.6 [27]
Cell death due to drug, μ 1.2 min−1 1739 [8]
Receptor production rate, c1 4.98 × 10−22 mol cell−1 min−1 43.478 estimate
Maximum receptor recycling rate, c2 4.98 × 10−22 mol cell−1 min−1 43.478 estimate
Half maximum receptor recycling concentration, c3 2.76 × 10−20mol cell−1 83.28 estimate
Hill exponent (receptor recycling), α - 1 estimate
Hill exponent (cell death), β - 1 estimate
Receptor scaling factor, ν - 8.414 × 10−5 estimate
Scaling parameter, η - 0.02 estimate
https://doi.org/10.1371/journal.pone.0254208.t001
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system as follows:
m ¼ m̂K; V ¼ V̂V0; F ¼ F̂F0KNA; Bi ¼ B̂iV0;




where i = 1, . . ., n and the non-dimensional variables are denoted by hats. Removing the hats
for notational convenience the rescaled system then reads
dm
dt
¼ mð1   mÞ   ~gð~�Þm; ð12Þ
dV
dt






¼ ~kaLF   ~kdB1   ~kinB1




¼ ~kaðrll   ði   1ÞÞrf FBi  1   i~kdBi   ~kinBi




¼ ~kaðrll   ðn   1ÞÞrf FBn  1   ~kinBn   n~kdBn; ð16Þ
dF
dt
¼   Z~kaFL   Z~ka
Xn
i













Bi   ~dbBin; ð18Þ
dP
dt
¼ ~n~dbBin   ~dpP; ð19Þ
with
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The rescaled system is then subject to the following initial conditions,
mð0Þ ¼ 1; Vð0Þ ¼ 1; Fð0Þ ¼ 1; Bið0Þ ¼ 0; Binð0Þ ¼ 0; Pð0Þ ¼ 0; ð21Þ
for i = 1, . . ., n. The values of the rescaled parameters are given in Table 1. We see that in the
rescaled system the larger parameters (on the order of or close to 103) are the internalisation
rate, kin, the polymersome rupture rate, db, the drug decay rate, dp, the natural cell death rate,
dm, and cell death due to drug, μ, so we expect that these will have large influences on the sys-
tem. On the other hand the initial binding rate, ka, and the dissociation rate, kd, are small (less
than one) so we expect these to have a negligible impact on the system.
We solve the system numerically using the ODE solver ode45 in Matlab, which is based
on the explicit Runge-Kutta 45 method. Fig 3 shows representative results for a typical set of
parameter values, given in Table 1. Initially there is a quick decrease in free receptors due to
the fast initial binding with ligands on the polymersome surfaces, then a more gradual decline
is observed as the number of tumour cells, and hence, cell surface receptors decrease. With the
maximum number of complexes being set to twenty, the majority of polymersomes only create
a small number of bonds with the cell surface before being internalised, with the maximum
number of internalised polymersomes occurring after around one hour. The intracellular drug
concentration exhibits a similar behaviour as the internalised polymersomes. This is to be
expected as the drug release is assumed to be proportional to the rate of internalisation of poly-
mersomes. The simulations show that, for this specific set of parameter values, the tumour cell
population decreases to zero over time after polymersomes are introduced. The decrease is
rapid over approximately the first 10 hours and then slows as the population approaches zero.
2.4 Singular perturbation analysis
The results of the numerical system show rapid changes in the system at early time points.
This is to be expected based on the large coefficients we find in our nondimensionalisation.
To get an analytical handle on this we carry out a singular perturbation analysis of early time
points in the system. We use the non-dimensional system given in the previous section 2.3
with the hats and tildes dropped for convenience.
For simplicity, we first consider a single binding interaction, where only one complex
between a ligand and receptor has to form for the drug-loaded polymersome to be internalised
(n = 1). We justify this by observing that the binding rate is much smaller than the internalisa-
tion rate so that a polymersome will likely be internalised after one bond has formed and
before other bonds form. We do this by setting ρl = l−1 and ρf = 0 so that Bi(t) = 0 for 2� i� n.
For further simplification of the model we look at the parameters involved in the kinetics of
receptors and ligands. Note that, with the parameter values described in the previous section,
we have the dimensionless values, kd� O(10−2),
kd
l
� Oð10  5Þ and ηkd� O(10−4) and so we









where ε� 1 is
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a scaling parameter. We also look to simplify the saturating functions for receptor recycling,
R(btot), and cell death, g(ϕ), given by (20). The total cell death rate, g(ϕ), can be linearised





reduces to ~gð~�Þ ¼ ~dm þ ~m. To simplify Rð~btotÞ, we
assume that c3 is small compared to ~btot, so that R(b)� c1 + c2 ≔ R.
Before performing the analysis we make one further assumption in order to simplify the




¼ εmð1   mÞ   εgð�ÞP; ð22Þ
dV
dt
¼   εkaVF; ð23Þ
Fig 3. Predictions of the model (Eqs 12–19) for the parameter values given in Table 1. The nondimensional system and parameters were used for the
simulations and the results were converted to dimensional values. The maximum number on bons, n = 20.
https://doi.org/10.1371/journal.pone.0254208.g003
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dF
dt
¼   kaZlVF   df F þ Rm; ð24Þ
dB
dt






B   εdbBin; ð26Þ
dP
dt
¼ εndbBin   εdpP; ð27Þ
whilst initial conditions remain the same as those given in Eq (21).
Using this reduced system we look to find the inner solutions of the system. We propose
asymptotic solutions of the form P(τ; ε) = ∑n = 0 εn Pn, m(τ; ε) = ∑n = 0 εn mn, V(τ; ε) = ∑n = 0 εn
Vn and F(τ; ε) = ∑n = 0 εn Fn and equate coefficients of powers of epsilon to look for the inner
solutions for free polymersomes and free receptors at early time points. For coefficients of ε0,
the solutions for m and P are m = 1 and P = 0, as given by the initial conditions. These solu-
tions allow us to solve the leading order solution for free receptors, F, and free polymersomes,
V, with the equations for bound polymersomes (B) and internalised polymersomes (Bin)





Solving this with the initial condition V(0) = V0, the leading order solution is then given simply
by
V0ðtÞ ¼ V0: ð29Þ





0ðtÞ   df ÞF
0ðtÞ þ Rm; ð30Þ








b ¼ kaZlV0 þ df ; ð32Þ
and C1 is a constant of integration,




During this time period free polymersomes become bound to cells (see Fig 3). Thus the
number of free polymersomes V0(t) should not be equal to a constant. Equating coefficients of
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which can be easily solved to give












Next we find solutions for bound and internalised polymersomes. Recalling the solutions




















þ C3e  kint ð38Þ
where C3 is a constant of integration,








We now use the solution for bound polymersomes, (38), to solve for internalised
polymersomes.
By combining the equation for Bin(τ) (26) and by using (31), leads to
dBin
dt
¼ g1 þ g2e
  bt þ g3e
  kint þ C3e
  kint   dbBin ð40Þ

























PLOS ONE A mathematical investigation into the uptake kinetics of nanoparticles in vitro
PLOS ONE | https://doi.org/10.1371/journal.pone.0254208 July 22, 2021 13 / 35











The numerical and analytical results for bound and internalised nanoparticles are shown in
Fig 4(A) and 4(C) along with the relative error between the solutions (B,D). We find a good
match between the dimensionless numerical and analytical solutions at early time points
which is demonstrated by the relative error between the solutions. The numerical and analyti-
cal solutions are shown for up to seven minutes in order to capture the key behaviour at early
time points, that is that the maximum number of bound polymersomes occurs at a turning
point, but the relative error is shown for a longer time period to demonstrate the validity of the
results.
The relative error for bound and internalised polymersomes is shown in Fig 4 for the time
period 0� t� 60 minutes. For the bound polymersomes we see that for the first twenty min-
utes of the simulation the relative error is a few percent, after which the error grows with time.
Fig 4. Numerical and analytical solutions for (A) bound and (C) internalised polymersomes for up to seven minutes and (B,D)
the relative error in the numerical and analytical solutions for bound and internalised polymersomes respectively for up to one
hour. The numerical solution is the original model but with some simplifying assumptions, given by Eqs 25 and 26, and the analytical
solutions are derived from these via a perturbation analysis. The analytical solutions are given by Eqs 38 and 44. The nondimensional
system and parameters were used for the simulations and the results were converted to dimensional values. The parameters used are
given in Table 1.
https://doi.org/10.1371/journal.pone.0254208.g004
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For the internalised polymersomes the relative error remains below 0.5%. Therefore, we take
the analytical solutions to be acceptable for early time periods, less than ten minutes, in the
model.
2.5 Maximising polymersome uptake
In Fig 4 we observe that the maximum number of bound polymersomes occurs at a turning
point so now we look for an approximated analytical value of this maximum.
Differentiating (38) and solving at zero, the turning point occurs at t = t�, where








therefore the maximum of number bound polymersomes, Bmax, is then given by

















Similarly, we can find the maximum of internalised polymersomes. We see from Fig 4 that
at early time points the concentration of internalised polymersomes increases with time.





We use this result to investigate the importance of different parameters on polymersome
internalisation which subsequently affects the delivered chemotherapy drug concentration.
2.6 Parameter dependency of maximum bound and internalised
polymersomes
Fig 3 reveals rapid system dynamics at early time points. To understand this behaviour in
more detail we performed a singular perturbation analysis, the predictions for which are
shown in Fig 4. From the analytical results we derived expressions for the maximum bound
and internalised polymersomes. Fig 5 shows the behaviour of these quantities when we vary
key parameters. In Fig 5, we observed that Bmax is an increasing function of l, the fixed number
of ligands per polymersome. The internalised polymersomes initially increases as l increases to
reach a peak at approximately 500 ligands per polymersome before decreasing. As l continues
to increase the internalisation rate by tumour cells slows, indicating that there is an optimal
number of ligands to maximise polymersome internalisation. This is in agreement with the
work of Ghaghada et al. [21] who also found that a specific number of ligands maximises poly-
mersome uptake. Bmax and Bmaxin are both increasing saturating functions of ka, meaning with
increasing ka more polymersomes become internalised. On the other hand Bmax is a decreasing
saturating function of the scaling factor, η. The maximum number of internalised polymer-
somes increases rapidly with η before decreasing, indicating an optimal value.
Next we apply our model to a spheroid system in order to incorporate spatial effects of poly-
mersome delivery and to explore the impact of various internalisation factors on tumour
growth, as well as tissue properties such as permeability.
3 Spheroid model
Tumour spheroids are an alternative in vitro preclinical screening tool for cancer drug
development in addition to 2D monolayer experiments. Cells are seeded in a specially
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designed well; the cells cannot bind to the surface of the well so bind to each other and as
they multiply they grow in a spheroid shaped mass. Initially the seeded cells have plenty of
oxygen and nutrients to proliferate. However, oxygen and nutrient supply is diffusion-lim-
ited, so as the cell mass increases, some cells in the centre of the spheroid become located
beyond the supply of nutrients and oxygen required for respiration. This leads to a forma-
tion of a quiescent layer of cells that receive enough nutrients and oxygen to survive but not
to proliferate and at the centre of the spheroid no such supply is received and so cells die,
forming a necrotic core. The spheroid geometry also limits drug penetration. The growth
of the spheroid therefore leads to gradients in oxygen, nutrients and drugs from the surface
towards the core.
Fig 5. Sensitivity of the analytical solution of the maximum bound polymersomes and maximum internalised polymersomes, given by Bmax (first
column) and Bmaxin (second column), to variations in ligand number, l (first row), binding rate, ka, (second row) and the dimensionless scaling
parameter, η, (third row). The nondimensional system and parameters were used for the simulations and the results were converted to dimensional
values. The parameters used are given in Table 1.
https://doi.org/10.1371/journal.pone.0254208.g005
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Fig 6 shows a schematic of tumour spheroid growth with oxygen, nutrient and drug gradi-
ents as well as some example experimental results of nanoparticle penetration into tumour
spheroids over a period of 120hrs. It can been seen that it takes almost 24 hours for drugs to
penetrate the outer layer of the spheroid. At 120 hours the outer and middle layer of the spher-
oid are permeated with nanoparticles but the centre is mostly void of them.
Here we extend our monolayer model of nanoparticle delivery to cells to describe uptake in
a tumour spheroid, thus incorporating spatial effects. First we present the model, then explain
the basis of the functional dependencies in the constitutive relationships. We then present the
initial and boundary conditions of the model as well as any additional parameter values (see
Table 2) followed by nondimensionalisation. This allows us to study the impact of various
internalisation functions on spheroid growth over various time periods and various tissue
properties, such as permeability.
3.1 Mathematical formulation
We develop the model to describe radially symmetric avascular tumour growth with infiltrat-
ing polymersomes. The space is multiphase, accounting for cells and the surrounding material
such as water and cell debris, which is reflective of experimental conditions. The model incor-
porates the binding kinetics and release of polymersome carried chemotherapy drug and so
we can predict its associated impact on tumour growth.
In this model we do not account for certain physiochemical aspects of the nanoparticles,
such as the variability in size, and the electric or magnetic properties. Sorrell et al [15]
accounted for the variable sizes of the polymersomes, which occurs as a result of the
Fig 6. (A) Tumour spheroids grow from proliferating cells. As they grow over time quiescent and necrotic layers form due to gradients in oxygen and
nutrients. (B) An example of nanoparticle penetration over time in tumour spheroids. The images shown are slices through a HNSCC tumour spheroid.
Nanoparticles are rhodamine labelled PMPC-PDPA polymersomes. (left) 1 hour (middle) 24 hours, (right) 120 hours. Rhodamine fluorescence (red) and
DAPI counterstained cell nuclei (blue). Scale bar = 100μm.
https://doi.org/10.1371/journal.pone.0254208.g006
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production process, through the use of a stochastic model. The coating of polymersomes is
chosen specifically for biological environments such that they do not react with the environ-
ment in any adverse way and so investigating these properties is beyond the scope of this
work.
To setup the model we use dimensional parameters. The spheroid is a spherically symmet-
ric sphere of radius, R. We assume the spheroid is comprised of two continuous phases,
tumour cells and cellular material, as is common in the literature [17, 22, 28]. These phases are
described by the volume fraction per unit control volume of tumour cells, m(r, t) and cellular
material, w(r, t), which are functions of the distance from the spheroid centre, r, and time, t.
We also include transport of oxygen, c(r, t), via diffusion from the culture media surrounding
the spheroid, as well as distribution and binding of polymersomes. In order to simplify the
model we neglect the chemotherapy drug components and instead calculate cell death as a
function of polymersome concentration.
We apply a no-void condition within the spheroid, representing conservation of mass,
hence m + w = No, where No is a constant, given that m and w are normalised to a control vol-
ume of tumour cells.






























r2Jcð Þ   dcðm;wÞ;
ð51Þ
Table 2. Parameter values used in the spheroid model not already defined in Table 1.
Parameter Dimensional Value Dimensionless Value Reference
Random cell motility coefficient, Dm - 10 [29]
Random cellular material motility coefficient, Dw - 500 [29]
Oxygen diffusion coefficient, Dc 1 × 10−6cm2s−1 4 × 103 [19]
polymersome diffusion coefficient, Dv - 500 estimate
Maximum oxygen uptake by cells, pmaxcm - 0.05 [17]
Maximum oxygen uptake due to proliferation, pmaxcp 0.014 [17]
Maximum cell growth rate, pmaxm 6.944 × 10
−4min−1 - [17]
Maximum cell death rate, dmaxm - 2 [29]
Oxygen concentration for half maximal cell proliferation, cp - 0.6 [17]
Oxygen concentration for half maximal cell death, cc - 0.6 [17]
Potentcy, γ 10−3 estimate
Total volume fraction of cells and cellular material, N0 - 1 -
Radius of a cell, Rm 6μm - [29]
https://doi.org/10.1371/journal.pone.0254208.t002
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þ karf rllNa   ðn   1Þð ÞFBn  1
  ðnkd þ kinðnÞÞBn;
ð55Þ
where Jm, Jw, Jc and Jv are the fluxes of tumour cells, cellular material, oxygen and free polymer-
somes, respectively. The fluxes are given by
Jm ¼   Dm
@m
@r




Jc ¼   Dc
@c
@r





where v is the common advection velocity (the velocity of all constituents in the model due to
bulk motion) and Dm, Dw, Dc, Dv are the diffusivities of the tumour cells, cellular material, oxy-
gen and free polymersomes respectively. We assume that once the polymersomes have bound
to the cell then they move with the cell. Using the no-void condition and by summing Eqs (49)









Next, we discuss the functional forms of the terms in the model. The framework we are
using here has been adapted from similar work which models the use of therapeutic macro-
phages by Webb et al [17]. The function pm(w, c) denotes tumour proliferation, which we take
to be an increasing saturating function of both the cellular material and oxygen concentration,






and the death rate due to apoptosis, dm(c), is a decreasing function of the oxygen
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concentration,
dmðcÞ ¼ dmaxm ð1   Sðc; ccÞÞ: ð59Þ
We capture oxygen metabolism through the function dc(m, w, c) which increases with tumour
cell density,
dcðm;w; cÞ ¼ pmaxcm Sðc; ccÞmþ p
max











cp is the oxygen threshold for proliferation, cc is the oxygen concentration for half maximal cell
death, pmaxcm is the maximum uptake rate of oxygen by cells, p
max
cp is the maximum uptake rate
of oxygen due to proliferation and pmaxm is the maximum cell growth rate under nutrient rich
conditions. S(c, cp) is a scaled Hill function with maximal value S = 1 when c = c1 (which we
assume is the maximum value of oxygen at the tumour boundary), with the steepness of the
curve dependent on the value of the exponent α> 0.
For simplicity the death of cells is a calculated as function of bound particles, reducing the
number of calculations needed in the model. We assume that the death rate of tumour cells,





where γ is the potency of the polymersomes. To further simplify the framework, we assume a
fixed number of receptors per cell, f0. So that, at any time, the free receptors per cell is given by













Using this model set up, we can solve Eqs (53)–(55) independently to give numerical equa-
tions for polymersomes with different bond numbers, i.e for each Bi, (where i = 1, . . ., n), in
terms of the remaining model variables. It is useful to solve for each Bi because this allows us to
perform investigations into how the number of bonds between polymersomes and cells effects
possible outcomes of spheroid growth. The values of the parameters that are introduced in this
section are given in Table 2, the rest of the parameters which were also used in the previous
section remain the same and are given in Table 1.
3.2 Initial and boundary conditions
Next we set the initial and boundary conditions for the model. Initially, the tumour is allowed
to grow without the presence of therapeutic polymersomes, as the spheroid would in experi-
ments, therefore at t = 0
mðr; 0Þ ¼ M0; wðr; 0Þ ¼ N0   M0; cðr; 0Þ ¼ c0; ð64Þ
Vðr; 0Þ ¼ 0; Bðr; 0Þ ¼ 0; V1 ¼ 0 and Rð0Þ ¼ R0; ð65Þ
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where V1 is the polymersome surface concentration, M0 is the tumour cell density, c0 is the
oxygen concentration, B(r, 0) is the bound polymersome concentration and V(r, 0) is the poly-
mersome concentration at distance r from the spheroid centre and R0 is the initial radius of
the spheroid. At some time, t�, we introduce the polymersomes on the surface of the tumour
spheroid by setting the surface concentration of polymersomes, to some non-zero value (previ-
ously V1 = 0 when 0< t< t�).















¼ 0 on r ¼ 0: ð66Þ
On the tumour boundary r = R(t), we fix the nutrient concentration, c = c1. Both cellular
material and polymersomes can move across the tumour boundary with their flux across the
boundary proportional to (w1 − w(R, t)) and (V1 − V(R, t)), respectively, where w1 is the
external concentration of cellular material. The tumour boundary moves with the velocity vm
and cellular material moves across the boundary at velocity vw, hence the flux boundary condi-
tions for cellular material and unbound polymersomes on r = R(t) are given by,









¼ hwðw1   No þmÞjr¼RðtÞ;
ð67Þ









¼ hvðV1   VÞjr¼RðtÞ;
ð68Þ
where hw and hv are the positive permeabilities of the cellular material and free polymersomes,
respectively, across the tumour boundary. The velocities of tumour cells, vm, cellular material,
vc, and free polymersomes, vv, are given by
















The boundary conditions for bound polymersomes, Bi’s, on r = 0 and r = R(t) can be found
assuming the bound polymersomes are in quasi steady state (discussed in section 3.4).
The spheroid boundary moves with the tumour velocity vm,
dR
dt

















hwðw1 þm   N0Þ: ð70Þ
Similarly to the well-mixed system we nondimensionalise due to the large variation in the
magnitude of parameter values and to allow us to identify dominant terms in the model.
3.3 Nondimensionlisation
In this section, the system of Eqs (49)–(55) is nondimensionalised alongside the counterpart
initial and boundary conditions to evaluate the dominant balance of different mechanisms.
We use the following re-scalings to nondimensionalise the system, where the hats denote the
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nondimensional variables,










r ¼ r̂Rm; v ¼ v̂Rmpmaxm ; l̂ ¼ lNa; t̂ ¼ p
max
m t;
where vm is the volume of a tumour cell, Rm is the radius of an individual tumour cell and c1
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The non-dimensional advection velocity then is as follows













































For convenience in the remaining analysis we drop the tildes.
3.4 Numerical solutions
Due to the fast timescale of oxygen diffusion (Dw = 1 × 10−6cm2s−1) compared to the timescale
of tumour growth (0.05cm/day) [19] we make the assumption that the oxygen concentration is
at quasi -steady state, as is common in the literature [19, 30]. The binding kinetics of the recep-
tors and ligands are fast compared to that of tumour cell growth, the binding rate, ka, is on the
order of 108mol−1min−1cm3 whereas cell division is on the order of 10−4min−1. This allows us
to make the assumption that bound polymersomes are in quasi steady state compared to cell
growth. We also note that the flux of cells is much lower than that of free nanoparticles and
oxygen, so comparatively the cells are stationary on the tissue scale of cell movement, growth
and decay. Thus the equations describing ligand-receptor complexes, Eqs (74)–(76), become
0 ¼ kalVF   ðkd þ kinð1ÞÞB1   karf ðrllNa   1ÞFB1 þ 2kdB2; ð78Þ
0 ¼ karf ðrllNa   ði   1ÞÞFBi  1   ðikd þ kinðiÞÞBi   karf ðrllNa   ði   1ÞÞFBi;
þðiþ 1ÞkdBiþ1; for i ¼ 2; :::; n   1;
ð79Þ
0 ¼ karf ðrllNa   ðn   1ÞÞFBn  1   ðnkd þ kinðnÞÞBn; ð80Þ






r2Jcð Þ   dcðm;wÞ: ð81Þ
We can now solve analytically for each Bi. First, we take n = 2, where the maximum number
of bonds per polymersome is 2. Eqs (78)–(80) then give
0 ¼ kalVðf0m   B1   2B2Þ   ðkd þ kinð1ÞÞB1
  karf ðrllNa   1Þðf0m   B1   2B2ÞB1 þ 2kdB2;
ð82Þ
0 ¼ karf ðrllNa   1Þðf0m   B1   2B2ÞB1
  ð2kd þ kinð2ÞÞB2:
ð83Þ
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g1 ¼ karf ðrll   1Þ; m1 ¼ kd þ kinð1Þ and m2 ¼ 2kd þ kinð2Þ: ð86Þ
Note that the algebraic system (78)–(80) with n = 3 is analytically intractable so we need to
make an additional simplifying assumption by introducing an additional approximation
to F. To do this we assume that there are many more free receptors than bound, so that
F �
Pn
i¼1 iBi, where i = 1, . . ., n, and we can make the approximation
F ¼ f0m; ð87Þ
which allows us to calculate Bi for n> 2. We solve the system for up to n = 5 (equations not
shown here for brevity).
With the solutions for Bi(r, t) we solve the nondimensionalised system (Eqs 71–73) with the









on r ¼ 0: ð88Þ


















¼ h1ðV1   VÞjr¼RðtÞ: ð90Þ
The spheroid boundary (r = R(t)) now moves with the tumour velocity so that
dR
dt
¼ hnðn1 þm   1Þ: ð91Þ
The system is solved numerically using NAG routine D03PHF which uses a finite difference
approach to integrate over one spatial variable and the method of lines to reduce the PDEs to
a system of ODEs. The resulting system is solved using a backward differentiation formula
method.
3.5 Spheroid growth before, during and after polymersome application
With the system solved numerically we can investigate impact of applying polymersomes to
tumour spheroid growth. Fig 7 shows the model predictions in space and time for tumour
cell density, oxygen concentration and free and total bound polymersomes for a constant
internalisation function and a maximum number of bonds, n = 5. The spheroid grows
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initially in the absence of oxidative stress. During this period we observe linear growth of the
spheroid radius, with a high concentration of proliferating cells at the surface which rapidly
decays to no proliferating cells towards the spheroid centre at r = 0, indicating a necrotic
core due to lack of oxygen. At time t = 40 days polymersomes are applied to the surface of
the spheroid, which are then removed at t = 50 days. During the period of polymersome
application, we observe a noticeable decrease in spheroid radius. The polymersomes are
confined to the boundary of the spheroid, where the chemotherapy drug is unloaded into
proliferating cells, causing the spheroid to shrink. As would be expected, the total bound
polymersomes follows a similar trend to free polymersomes. Once the polymersomes are
removed the cells at the edge of the spheroid become re-oxygenated due to the smaller radius
allowing for effective diffusion. This then provides a good environment for growth, hence
the spheroid re-grows linearly for t> 50 days.
Next we investigate the model predictions using two different internalisation functions.
Fig 7. Evolution of a tumour spheroid and associated variables in time, including the tumour cell, oxygen, free and bound polymersome
concentrations for n = 5. The cellular concentration is given as the volume fraction of live tumour cells. The rest of the concentrations are dimensionless.
Initially growth occurs with no free polymersomes on the tumour surface up to a radius of 175μm, then we introduce polymersomes by setting V1 = 10
when 40� t� 50 days. The tumour growth rate decreases and the spheroid shrinks for the period of time when treatment is administered, but returns to
linear growth (indicating travelling wave solutions) afterwards. The simulations were conducted using the dimensionless framework and the time and
distance converted to dimensional form afterwards. The parameter values used are give in Tables 1 and 2.
https://doi.org/10.1371/journal.pone.0254208.g007
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3.6 Effects of constant and bond dependent internalisation functions
It has been assumed so far in this paper, and in our previous work, that internalisation is con-
stant. However, it is possible that internalisation is bond dependent so we also define a bond
dependent internalisation function, in addition to the constant function. The bond dependent
function is a simple step-wise Hill function
kinðiÞ ¼ kinðε1 þHði   j�ÞÞ; ð92Þ
where ε1 is a small number. In this scenario polymersomes are not internalised until they
reach the bond number specified by the activator, j�.
In Fig 8A we show the model predictions for tumour radius using the constant internalisa-
tion function for n = 1 � � � 5. As before the tumour is allowed to grow until t = 40 days at which
point polymersomes are applied until t = 50 days. We see very little variation in the predictions
Fig 8. The impact of polymersomes on the spheroid dynamics using the numerical solutions for bonds. (A) Tumour radius dependency on the
maximum number of bonds, n, for the constant internalisation function. The maximum bond number is varied from n = 1 � � � 5. (B) (C) The tumour
radius with time for a bond dependent internalisation function for various values of the activator, j�. Polymersomes are applied to the tumour surface at 40
� t� 50 days with the parameters V1 = 10, the rest of the parameter values used are give in Tables 1 and 2. (B) Polymersome application and growth over
80 days (C) Polymersome application and growth over a much longer time period of 2500 days.
https://doi.org/10.1371/journal.pone.0254208.g008
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which implies internalisation happens quickly before multiple bonds can form. This is in
agreement with our predictions in the well-mixed system (see Fig 3). In Fig 8B and 8C, we
show the predictions for the case of the bond dependent function. Fig 8 indicates that when
the activator, j� � 4, there is a decrease in spheroid radius during the period of treatment
comparable to that of constant internalisation, but if j� > 4 there is no reduction in spheroid
growth during the treatment time. Therefore, with this set of parameters j� = 5 appears to be a
threshold. That is, by forcing the polymersome to bind to at least 5 complexes before internali-
sation we slow down the internalisation of the polymersome sufficiently so that treatment
is then not effective within this time frame. Fig 8 also shows longer term solutions, for 0�
t� 2500 days. We find that over long time periods the model predictions tend to the same
solution.
3.7 Large time behaviour
In the absence of polymersomes the tumour spheroid appears to grow linearly (see Fig 7). In
order to find exact solutions for this behaviour we look to the asymptotic solutions of the sys-
tem as t!1 and hence we carry out a travelling wave analysis by assuming that the tumour
grows with constant speed, u> 0.




so that R� ut as t!1. We redefine our system with the travelling wave coordinate, z = r −






0   mvÞ0 þ pmðw; cÞm   dmðcÞm   gðBÞ; ð94Þ
c@ ¼ dcðm;wÞ; ð95Þ




0   VvÞ þ ðDmV




where the prime denotes the derivative with respect to z. We use the quasi-steady state expres-
sions for bound polymersomes as described in Eqs 84 and 85. The advection velocity can be
written as
v ¼ cm0 where c ¼ Dm   Dw: ð97Þ
The system is represented by the following first order ODEs,
m0 ¼ W; ð98Þ
c0 ¼ P; ð99Þ




uW   cW2 þ pmðw; cÞm   dmðcÞm   gðBiÞð Þ; ð101Þ
P0 ¼ dcðm;wÞ; ð102Þ
PLOS ONE A mathematical investigation into the uptake kinetics of nanoparticles in vitro










for i = 1, . . ., n. Note that we have neglected the terms containing r−1 since they are OðR  1Þ
when R!1.
We solve this system of equations numerically using AUTO (a bifurcation and continuation
software) [31]. To facilitate the solver we truncate the semi-finite domain ẑ 2 ð  1; 0� to ẑ 2







so that ẑ 2 ½0; 100�.
The wavespeed u can be written using 91
u ¼ hnðn1 þm   1Þjð̂zÞ¼100: ð105Þ
The system is subject to the following boundary conditions on the truncated domain
ẑ 2 ½0; 100�: at ẑ ¼ 0
m0ð0Þ ¼ c0ð0Þ ¼ V 0ð0Þ ¼ 0; ð106Þ
at ẑ ¼ 100,
  Dwm0   Dm
ð1   mÞ
m
m0 ¼ hwðw1 þm   1Þjẑ¼100; ð107Þ
DvV 0   Dm
V
m
m0 ¼ hvðV1   VÞjẑ¼100 ð108Þ
which follow from (88)–(90). The oxygen concentration is fixed at c = 1 when ẑ ¼ 100 (chosen
arbitrarily). We impose an additional boundary condition which fixes the wave speed u at
ẑ ¼ 100, given by u = hw(w1 + m − 1). This extra boundary condition allows us to use the
bifurcation and continuation AUTO software [31] to solve (98)–(103) to calculate the wave
speed, u.
3.8 Travelling wave solutions of spheroid growth
Fig 9 shows the wavespeed, u, against potency, γ, and external polymersome concentration,
V1. We can see that by increasing the potency of the polymersomes, γ, the wavespeed
decreases to zero (A), indicating a bifurcation from travelling waves (linear growth) to steady-
state where tumour growth is confined. As V1 increases we observe similar dynamics, i.e. a
greater concentration of polymersomes results in a more effective treatment (B).
In Fig 9, we also show the travelling wave:steady-state bifurcation in (V1,γ) parameter
space, with a varying external cellular material concentration, w1 (C). We can see that, with
increasing concentration of applied polymersomes, a lower polymersome potency is required
for steady state solutions. We would expect that by increasing w1 the tumour growth would
increase resulting in a larger parameter region for travelling waves. We have found that this is
true but only to a certain threshold value of w1, (D).
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Fig 9. Travelling wave and steady state solutions for the tumour spheroid model. (A) The travelling wave velocity, u, with varying potentcy, γ,
and fixed polymersome concentration at the spheroid boundary, V1 = 2, and (B) travelling wave velocity with varying V1 and fixed γ = 1 × 10−4.
(Middle and bottom) Travelling wave: steady state bifurcation curves. (Middle row) Bifurcation curves for γ with (C) various external polymersome
concentrations, V1 and fixed external nutrient concentration w1 = 1 � � � 5, and (D) with various cellular material concentrations, w1, and a
constant polymersome concentration, V1 = 5. In (E) we see the bifurcation in the polymersome diffusivity and spheroid permeability parameter
space. The rest of the parameter values used are give in Tables 1 and 2.
https://doi.org/10.1371/journal.pone.0254208.g009
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In Fig 9(E) we explore the travelling wave:steady-state bifurcation in relation to the diffu-
sion of the polymersomes and the permeability across the spheroid boundary. We notice that
for a fixed value of hv (for example, if hv = 2.2) the solutions can be either travelling waves for
very small or very large values of Dv, but steady state solutions occur for intermediate values
of Dv.
Finally, we examine the relationship between γ, V1 and w1 further by fixing V1 and fol-
lowing the travelling wave, steady state bifurcation in (w1,γ) parameter space. In Fig 10, we
examine the behaviour of the tumour cells and the internal velocity field within the tumour
spheroid for these parameter values. Typically the advection velocity within the spheroid is
negative, which means that material is advected into the centre of the spheroid. However,
when increasing w1 over a certain threshold, we see that the advection velocity becomes
positive near the spheroid boundary, this change in the direction of the velocity results in the
polymersomes being kept at the tumour boundary where the tumour density is highest. As a
Fig 10. In (A, B) and (C) are the solution profiles for tumour cells, free polymersomes and oxygen, respectively, at varying values of external nutrient
concentration, w1 = 0.2 (blue),0.4,0.6,0.8 (purple). (D) Advection velocity with w1 = 0.2, 0.4, 0.6, 0.8. We see a positive velocity at the tumour boundary
with larger values of w1. The rest of the parameter values used are give in Tables 1 and 2.
https://doi.org/10.1371/journal.pone.0254208.g010
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consequence more viable cells are being targeted and subsequently a lower polymersome
potency (γ) is required to give the same reduction in tumour size. We also show how the free
polymersome and oxygen density vary over the spheroid radius for various value of w1.
4 Discussion
A mathematical model for nanoparticle uptake via receptor-mediated endocytosis has been
presented. The model is applied to two scenarios representative of relevant experimental
designs for tumour therapy development. Firstly, the model was applied to cells in a well-
mixed system, representative of 2D monolayer cells and polymersomes in a tissue culture
flask, and secondly to investigate dynamics of growth in a tumour spheroid during and after
polymersome application. For both approaches the model is nondimensionalised in order to
evaluate the dominant features. The well-mixed system was investigated first which allowed
spatial effects to be neglected, with a focus on the binding kinetics of the model.
The nondimensionalisation of the well-mixed model indicated that polymersomes are
internalised after forming one bond with the cell, since the internalisation rate is several orders
of magnitude higher than the binding rate (see Table 1). Based on this we made the assump-
tion that the maximum number of bonds is low throughout the rest of the investigation. In the
singular perturbation analysis, a single binding event is assumed and the system is further sim-
plified by neglecting the polymersome dissociation rate, which is small compared to uptake,
and linearising the functions that describe receptor recycling and cell death. These changes did
not affect the observed early time system dynamics.
By carrying out this analysis some important biological insights regarding the early kinetics
of the polymersome uptake are discovered. It was found that the maximum value for internal-
ised polymersomes corresponds to a particular value of ligands approximately 500 (see Fig 5
which is consistent with the literature [21]. Hence this reinforces the hypothesis that there is
an optimal number of ligands per polymersome. The findings from the perturbation analysis
can be extremely useful for biologists working on nanoparticle targeted therapy as the number
to targeted ligands on polymersomes is specific to the polymersome structure which can be
modified during the manufacturing of the polymersomes. This approach could easily be
applied to other types of nanoparticle to guide experimental design.
The findings from the well-mixed system were used in the spheroid model. In the well-
mixed system internalisation happens at a low number of bonds which meant that during the
simulations the maximum number of bonds, could be capped at a low number, reducing the
required mathematical work load.
The spheroid consists of two phases, tumour cells and cellular materials, similar to the
approach of the seminal work by Ward and King [22] and Byrne et al [32]. The novelty of this
approach is the use of the spheroid model to understand polymersome uptake and distribution
in a system which mimics polymersome delivery from a source. The growth of the spheroid
depends on available nutrients which diffuse across the spheroid boundary. A quasi-steady
state assumption is made for bound polymersomes. Although the spheroid does not have vas-
culature, by placing the nanoparticles on the cell surface we can understand how cells will be
affected at varying distances from a nanoparticle source, for example a blood vessel, by looking
at the gradient from the polymersome source at the tumour surface to the cells towards the
centre of the spheroid.
From Table 2 we see that the diffusion coefficient for oxygen is an order of magnitude
higher than that of the polymersomes, since oxygen is a much smaller molecule. This implies
that oxygen should diffuse further into the spheroids than the polymersomes over a given time
period meaning some cells may able to proliferate that aren’t reached by the polymersomes.
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After application of polymersomes to the spheroid surface it was found that the highest con-
centration of free polymersomes occurs at the boundary. As the spheroid shrunk due to cell
kills by polymersomes, the polymersomes moved closer to the spheroid centre due to the
reduction in spheroid radius. At all time points during the polymersome application the poly-
mersomes remain close to the surface. This is likely to be because there is a high density of pro-
liferating tumour cells and this density poses a barrier to diffusion. The same is also seen for
oxygen, albeit oxygen does penetrate further into the spheroid. The limitation of oxygen to the
spheroid periphery results in a necrotic core which arises naturally from our simulations and
is in agreement with experimental findings [16, 18, 33, 34].
Two internalisation functions are considered for multiple binding events. A constant func-
tion is considered, which was also used in the well-mixed system, as well as a more biologically
realistic internalisation function, in which a polymersome must be bound by a given number
of complexes before internalisation can occur. The bond dependent function mimics the
membrane deformation that occurs during receptor-mediated endocytosis. We introduce an
approximation to the free receptor concentration as the multiple binding framework becomes
algebraically intractable to solve when the maximum number of bonds that can form is greater
than 2.
Numerical simulations indicate that the spheroid radius is dependent on the internalisation
function. The bond dependent function requires the polymersomes to reach the value of the
activator before being internalised. For values of the activator below 5, the predictions of the
constant and bond dependent functions match. However, as the activator is increased to 5 the
polymersomes do not impact the growth of the spheroid, indicating a threshold value exists
for effective treatment over the time period tested. Therefore, we conclude that internalisation
function plays a critical role in treatment success and effects model predictions.
For the case of the bond dependent internalisation function we found that the number of
bonds required before internalisation had a short term effect on the tumour radius, but over
long time periods the solutions were the same. Due to this result, if multiple polymersome
applications were to be considered, it can be hypothesised that the time between administra-
tion could result in either a decrease in spheroid size or no effect, depending on the value of
this threshold.
Various nutrient concentrations in the space surrounding the spheroid were explored. It
was found that, up to a threshold, with increasing nutrient concentration there was an increase
in growth and more potent polymersomes were to attain saturated growth. After the threshold
the model predicts that we are more likely to see saturation of growth when using less potent
polymersomes. In this case, the internal velocity within the spheroid came into play. By
increasing the nutrient concentration past the threshold, the gradient of cellular material
switched direction, creating an opposite internal velocity, causing the polymersomes remained
close to the spheroid edge. This indicates that the nutrient concentration in the media should
be considered when designing experiments.
The influence of permeability of the spheroid surface and the polymersome diffusion rate
on spheroid growth was also explored. It was found that for certain values of permeability
spheroid growth or saturation was possible, although a lower permeability generally resulted
in steady-state solutions. For very small or very large values of the polyermsome diffusivity,
travelling waves occur whereas intermediate values result in growth saturation. This implies
that nanoparticles should be designed with intermediate diffusion coefficient and a high per-
meability to the spheroid boundary in order to restrict spheroid growth.
It should be noted that a number of key assumptions were made, and parameter values
were estimated or drawn from similar, but not the same models and data sets were used in
order to achieve these results. Therefore, the results are valid for the parameter set we have
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used, but this parameter set may be subject to change once further experimental data can be
obtained which could influence the system dynamics. For example a number of simplifying
assumptions were made based on the size of some parameters, such as the dissociation con-
stant was assumed to be negligible. Likewise, the numerical solutions presented in section 3.4
for the spheroid model make a number of assumptions about the quasi-state regimes. If these
parameters and assumptions are found to be significantly different from the ones we have used
this could have significant impact on the model predictions and analytical tractability of the
model.
However, these assumptions and parameter choices were made due to the lack of available
experimental data on which to base the work, and in fact the lack of experimental data is one
of the key motivations for this work. The processes which are modelled in this paper, particu-
larly of cellular uptake of polyermsomes, and subsequent release of chemotherapy drug, is
extremely difficult, if not impossible to image for each part of the process given current tech-
nology and so mathematical modelling offers an alternative to this.
Despite the difficulty in finding data to parameterise the model, the results still offer key
insights into the system dynamics and has highlighted which parameters are important to
know accurately. The use of two different systems, one reflective of a 2D monolayer and one of
3D tumour spheroid, has allowed various characteristics of polymersome uptake to be eluci-
dated, particularly over various time periods with respect to uptake of polymersomes by cells,
as well as allowing the use of parameter values predicted in the well-mixed system to be used
in the spheroid model. The agreement of the models on certain kinetics strengthens the con-
clusions that can be made. Both approaches revealed that most polymersomes are internalised
after only a few bonds are made between the polymersome and cell.
5 Conclusion
We have demonstrated the application of a new model of cellular uptake of nanoparticles, for
example polymersomes, via receptor-mediated endocytosis that is parameterised with experi-
mental data to investigate uptake in tumour spheroids. We make predictions about nanoparti-
cle design, namely the number of ligands on the surface and diffusion and permeability
coefficients, which can be fed into future experimental work. We have also shown that, over
long time periods, spheroid growth is independent of polymersome internalisation function
and that polymersome distribution is limited to the outer edge of the spheroid, close to their
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